CompletedPhase 2ACTRN12611001150932

Dyslipidaemia, Oxidative Stress And Arterial Wall Function In Non-Insulin Dependent Diabetes

A Double-Blind Randomised Placebo-Controlled Trial Of The Effects Of Fenofibrate And Coenzyme Q10 On Arterial Function In Type 2 Diabetic Subjects With Dyslipidaemia

Sponsor

Professor Gerald F Watts

Enrollment

80 participants

Start Date

Feb 1, 1997

Study Type

Interventional

Conditions

Type 2 Diabetes Dyslipidaemia

Summary

To assess whether the combination of fenofibrate and coenzyme Q improves vascualr health in diabetes

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Plain Language Summary

Simplified for easier understanding

This study examines the relationship between abnormal blood fats (dyslipidaemia), oxidative stress, and blood vessel function in people with Type 2 diabetes who are not on insulin. Participants must be aged 18 to 75 with specific cholesterol and triglyceride levels. People taking lipid-lowering drugs, antioxidants, or certain blood pressure medications are excluded.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.